EMEA-002685-PIP02-19-M01

Table of contents

Key facts

Invented name
Vumerity
Active substance
Diroximel fumarate (BIIB098)
Therapeutic area
Neurology
Decision number
P/0413/2022
PIP number
EMEA-002685-PIP02-19-M01
Pharmaceutical form(s)
Gastro-resistant capsule, hard
Condition(s) / indication(s)
Treatment of multiple sclerosis
Route(s) of administration
Oral use
Contact for public enquiries
Biogen Netherlands B.V.

E-mail: pip.enquiries@biogen.com
Tel. +44 1628 512669

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating